Forte Biosciences Inc. (FBRX) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Forte Biosciences Inc.

    NASDAQ: FBRX · Real-Time Price · USD
    11.06
    -0.07 (-0.63%)
    At close: Sep 09, 2025, 3:59 PM
    11.10
    0.36%
    After-hours: Sep 09, 2025, 04:56 PM EDT

    Forte Biosciences Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -35.48M -31.48M -13.88M -21.71M
    Depreciation & Amortization
    		 39K 9K n/a 36K
    Stock-Based Compensation
    		 3.1M 3.28M 4.01M 4.21M
    Other Working Capital
    		 -1.26M -663K 1.47M 1.01M
    Other Non-Cash Items
    		 -158K -131K 3.81M 61K
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 1.76M -392K 1.68M 720K
    Operating Cash Flow
    		 -30.75M -28.71M -8.19M -16.68M
    Capital Expenditures
    		 -37K -88K n/a n/a
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 -35.96M -9.96M n/a n/a
    Sales Maturities Of Investments
    		 n/a 10.1M n/a n/a
    Other Investing Acitivies
    		 n/a n/a n/a n/a
    Investing Cash Flow
    		 -35.99M 47K n/a n/a
    Debt Repayment
    		 n/a n/a n/a n/a
    Common Stock Repurchased
    		 -1K n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 -1.14M -44K 12K -44K
    Financial Cash Flow
    		 51.86M 24.68M 7.24M -44K
    Net Cash Flow
    		 -14.88M -3.98M -944K -16.72M
    Free Cash Flow
    		 -30.78M -28.79M -8.19M -16.68M

    Add to Watchlist